Andrew Leslie Denver
Founder presso The Principals Funds Management Pty Ltd.
Patrimonio netto: 927 915 $ in data 31/03/2024
Profilo
Andrew Leslie Denver was the founder of PFM Cornerstone Ltd.
(founded in 2007) and held the title of Director.
He is also the founder of The Principals Funds Management Pty Ltd., Australian Environment Management Export Corp.
Ltd., and Environment Management Industry Association of Australia.
Mr. Denver's current job(s) include being the Non-Executive Chairman at SpeeDx Pty Ltd.
(since 2009), Non-Executive Director at Vaxxas Pty Ltd.
(since 2012), Non-Executive Director at Vaxxas, Inc., Director at Qbiotics Pty Ltd., and Non-Executive Director at Qbiotics Group Ltd.Mr. Denver's former job(s) include being the Chief Executive Officer at Universal Biosensors, Inc. (from 2002 to 2017), Non-Executive Director at CathRx Ltd.
(from 2005 to 2010), Independent Non-Executive Director at Cochlear Ltd.
(from 2007 to 2023), Non-Executive Director at Roc Oil (Vic) Pty Ltd.
(from 2006 to 2008), Director at The Principals Cornerstone Fund Pty Ltd., Director at Universal Biosensors Pty Ltd.
(from 2002 to 2005), President-Medical Devices Division at Baxter Healthcare Corp., President-Filtration & Separations Business at Pall Corp.
(from 2002 to 2005), President, Chief Operating Officer & MD at Memtec Ltd.
(from 1987 to 1997), President & Chief Operating Officer at USFilter Corp., and President at Pall Asia International Ltd.
(from 2002 to 2005).
Mr. Denver's education history includes an undergraduate degree from The University of Manchester and an MBA from Harvard Business School.
Mr. Denver is also the founder of The Principals Funds Management Pty Ltd., Australian Environment Management Export Corp.
Ltd., and Environment Management Industry Association of Australia.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
COCHLEAR LIMITED
0.01% | 17/10/2023 | 4 214 ( 0.01% ) | 927 915 $ | 31/03/2024 |
Posizioni attive di Andrew Leslie Denver
| Società | Posizione | Inizio |
|---|---|---|
| The Principals Funds Management Pty Ltd. | Founder | - |
SpeeDx Pty Ltd.
 SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Chairman | 01/01/2009 |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Director/Board Member | 01/01/2012 |
| Vaxxas, Inc. | Director/Board Member | - |
| Qbiotics Pty Ltd. | Director/Board Member | - |
| Qbiotics Group Ltd. | Director/Board Member | - |
Precedenti posizioni note di Andrew Leslie Denver
| Società | Posizione | Fine |
|---|---|---|
| COCHLEAR LIMITED | Director/Board Member | 17/10/2023 |
| UNIVERSAL BIOSENSORS, INC. | Chief Executive Officer | 01/10/2017 |
CathRx Ltd.
 CathRx Ltd. Medical SpecialtiesHealth Technology CathRx Ltd. manufactures and develops electrophysiology catheters for the diagnosis and treatment of cardiac arrhythmias. Its products include ablation EP catheters, loop EP catheters, steerable EP catheters, and fixed EP catheters. The company was founded on 31st August, 1999 and is headquartered in Homebush Bay, Australia. | Director/Board Member | 13/09/2010 |
| ░░░ ░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Andrew Leslie Denver
| The University of Manchester | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| UNIVERSAL BIOSENSORS, INC. | Health Technology |
| COCHLEAR LIMITED | Health Technology |
| Aziende private | 18 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
| Memtec Ltd. | Producer Manufacturing |
CathRx Ltd.
CathRx Ltd. Medical SpecialtiesHealth Technology CathRx Ltd. manufactures and develops electrophysiology catheters for the diagnosis and treatment of cardiac arrhythmias. Its products include ablation EP catheters, loop EP catheters, steerable EP catheters, and fixed EP catheters. The company was founded on 31st August, 1999 and is headquartered in Homebush Bay, Australia. | Health Technology |
Roc Oil (Vic) Pty Ltd.
 Roc Oil (Vic) Pty Ltd. Oil & Gas ProductionEnergy Minerals Roc Oil (Vic) Pty Ltd. explores oil and gas. It operates oil and gas fields and maintains a significant equity interest in future ventures. The company was founded on December 16, 2003 and is headquartered in North Sydney, Australia. | Energy Minerals |
USFilter Corp.
 USFilter Corp. Wholesale DistributorsDistribution Services USFilter Corp. was manufacturing wastewater-treatment equipment in the US and worldwide. The company was providing services to municipal, industrial and institutional clients through its Water and Wastewater Systems, Water Services and Products groups. Siemens acquired the company in 2004. USFilter was located in Warrendale, PA. | Distribution Services |
| The Principals Cornerstone Fund Pty Ltd. | |
PFM Cornerstone Ltd.
 PFM Cornerstone Ltd. Investment ManagersFinance PFM Cornerstone Ltd is an early stage venture capital firm. The company was founded by Andrew Leslie Denver and Denis Michael Hanley in 2007 and is headquartered in Sydney, Australia. | Finance |
Universal Biosensors Pty Ltd.
 Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | Health Technology |
| The Principals Funds Management Pty Ltd. | |
Pall Asia International Ltd.
 Pall Asia International Ltd. Industrial MachineryProducer Manufacturing Part of Danaher Corp., Pall Asia International Ltd. is a Chinese company that manufactures and distributes fluid testing and medical devices. The private company is based in Hong Kong, Hong Kong. | Producer Manufacturing |
| Australian Environment Management Export Corp. Ltd. | |
| Environment Management Industry Association of Australia | |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Health Technology |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Health Technology |
| Vaxxas, Inc. | |
| Qbiotics Pty Ltd. | |
| Qbiotics Group Ltd. |
- Borsa valori
- Insiders
- Andrew Leslie Denver
